23andMe sold the rights to a drug it developed from its genetic database

·

·

23andMe sold the rights to a drug it developed from its genetic database

The genetics testing company 23andMe licensed the rights to a drug it developed in-house to a Spanish pharmaceutical company, Bloomberg reported. This is the first time that the company has directly sold a product it created using the genetic information …
See Original Article

2014 Fed Conundrum: How to Alert Markets Rates Were Going Up

By MARTIN CRUTSINGER and CHRISTOPHER RUGABER, AP Economics Writers. WASHINGTON (AP) — In her first year as Federal Reserve chair, Janet Yellen presided over a policy panel divided over the issue of how much longer the central bank could …
See Original Article

Firms on the move: Armanino distributes $50K to six nonprofits

The Association for Accounting Marketing is kicking off its 30th anniversary with a Facebook Live event to celebrate the occasion and reveal a new
See Original Article

Fitbit and Garmin are under federal investigation for alleged patent violations

On Friday, federal regulators announced that they are launching an investigation into wearable monitoring devices, including Fitbit and Garmin, after rival company, Philips, accused the companies of patent violations, as first reported by Reuters.
See Original Article

Philadelphia Energy Solutions unlikely to remain an oil refinery after auction

Today is the last day for buyers to bid on the 1,300 acres in South Philly formerly known as Philadelphia Energy Solutions: a now-bankrupt oil refinery which closed last year due to a destructive fire. However, after multiple bidders appeared initially be …
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.